Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
H.R. 4242 (118th Congress)
H.R. 4242 is a bill of the 118th Congress (2023–2025), in committee as of 2023-06-21; sponsored by Dan Crenshaw and 2 others.
https://ontology.bommaritollc.com/id/01a10f0f-d48e-76b7-bc32-99c4e1eafd1e
Elsewhere
Official pagewww.govinfo.gov
Sourcewww.govinfo.gov
Facts
| adms:identifier | |
| dcterms:date | 2023-06-21xsd:date |
| dcterms:temporal | |
| in committee | |
| primary sponsor | |
| prov:wasDerivedFrom | |
| schema:legislationIdentifier | H.R. 4242 |
| schema:legislationJurisdiction | |
| schema:legislationType | |
| schema:name | To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.en |
| schema:sponsor | |
| schema:url | |
| skos:prefLabel | H.R. 4242 (118th Congress)en |
| status | |
| status date | 2023-06-21xsd:date |